This topic contains a solution. Click here to go to the answer

Author Question: When the multiplier is ________, an autonomous decrease in investment of 200 billion decreases ... (Read 206 times)

mspears3

  • Hero Member
  • *****
  • Posts: 586
When the multiplier is ________, an autonomous decrease in investment of 200 billion decreases equilibrium real GDP by 400 billion.
 
  When the multiplier is ________, an autonomous decrease in investment of 200 billion decreases equilibrium real GDP by 800 billion.
  A) 2.0; 4.0
  B) 0.4; 0.2
  C) 0.2; 0.4
  D) 4.0; 8.0
  E) 400 billion; 800 billion

Question 2

The demand for money curve is shown in the figure above. A movement from point B to point C could be the result of
 
  A) a rise in the real interest rate.
  B) an increase in the quantity of money held by banks.
  C) a fall in the nominal interest rate.
  D) a rise in the real interest rate matched by an equal fall in the nominal interest rate.
  E) a decrease in the total benefit from holding money.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jesse.fleming

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

A

Answer to Question 2

C




mspears3

  • Member
  • Posts: 586
Reply 2 on: Jun 29, 2018
Wow, this really help


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library